Economic evaluation of innovative technologies in health care should include a short-run perspective

被引:0
作者
Eddy M. M. Adang
机构
[1] Radboud University Nijmegen Medical Center,Department of Epidemiology, Biostatistics, and HTA
来源
The European Journal of Health Economics | 2008年 / 9卷
关键词
Short-run efficiency; Long-run efficiency; Cost-effectiveness analysis; Diseconomies of scale; Scope and learning;
D O I
暂无
中图分类号
学科分类号
摘要
Knowledge about the cost-effectiveness of innovative technologies or new guidelines in health care is more and more a necessary condition for implementation in common practice. However, there are situations where implementation of a new technology that is found more effective and cost effective and is strongly advocated by the medical profession stagnates. The reason for this is the discrepancy between long-run efficiency, on which cost effectiveness is based, and short-run efficiency. This paper addresses the potential paradox between long-run and short-run efficiency in health care and explores possibilities to overcome hurdles to implementation due to that paradox.
引用
收藏
页码:381 / 384
页数:3
相关论文
共 27 条
  • [1] Aletras A.(1999)Comparison of hospital scale effects in short run, long run cost functions Health Econ. 8 521-530
  • [2] Elbasha E.H.(2004)Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale Health Econ. 13 21-35
  • [3] Messonnier M.L.(1994)Cost and efficiency in nursing homes: a stochastic frontier approach J. Health Econ. 13 281-300
  • [4] Vitaliano D.(1992)Quality-adjusted cost functions and policy evaluation in nursing home industry J. Polit. Econ. 100 1232-1256
  • [5] Toren M.(1989)The costs of medicare patients in nursing homes in the United States : a multiple output anapysis J. Health Econ. 8 253-270
  • [6] Gertler P.(1987)Economies of scale, scope in the provision of home health services J. Health Econ. 6 129-146
  • [7] Walman D.(2005)Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions Health Policy 74 146-156
  • [8] Dor A.(1999)The distribution of variable vs fixed costs of hospital care JAMA 281 644-649
  • [9] Kass D.(2002)Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment Br. J. Dermatol. 147 538-544
  • [10] Adang E.(1976)Theory of the firm: managerial behavior, agency costs and ownershipstructure J. Financ. Econ 3 305-360